Nijdam Anna 4
4 · Pharvaris N.V. · Filed May 26, 2026
Research Summary
AI-generated summary of this filing
Pharvaris (PHVS) Anna Nijdam, Principal Accounting Officer, Exercises Options & Sells Shares
What Happened
- Anna Nijdam, Principal Accounting Officer at Pharvaris (PHVS), exercised stock options and immediately sold the resulting shares in cashless transactions. On 2026-05-21 she exercised 1,829 options at $20.00 (cost $36,580) and sold those 1,829 shares at a weighted average of $30.60 for $55,971. On 2026-05-22 she exercised 5,501 options at $20.00 (cost $110,020) and sold those 5,501 shares at a weighted average of $30.74 for $169,084. Total shares sold = 7,330; total gross proceeds reported ≈ $225,055; total exercise cost = $146,600 (7,330 shares × $20).
Key Details
- Transaction dates and prices:
- 2026-05-21: exercised 1,829 shares @ $20.00; sold 1,829 shares @ weighted avg $30.60 (sales ranged $30.60–$30.61 per F2).
- 2026-05-22: exercised 5,501 shares @ $20.00; sold 5,501 shares @ weighted avg $30.74 (sales ranged $30.60–$31.00 per F3).
- Shares sold: 7,330 total; gross sale proceeds ≈ $225,055; exercise outlay ≈ $146,600.
- Beneficial ownership: filing corrects a previous RSU tax-withholding error — total beneficial ownership as of April 11, 2026 should have been 48,945 shares (vs. 48,940 reported earlier) per footnote F1. The exercised shares were sold in the same transactions, so reported beneficial ownership remained effectively unchanged in the filing.
- Vesting note: the option plan vests 25% on Feb 5, 2022 with the remainder vesting monthly over 36 months (footnote F4).
- Sales were cashless exercises (footnotes F2 & F3); weighted average prices reported reflect multiple trades. The filer offers to provide per-trade price breakdown on request.
Context
- This was an option exercise combined with immediate sale (cashless exercise). That typically reflects exercising vested options while selling shares to cover the exercise price and tax withholding; it is routine and does not necessarily signal a change in insider sentiment.
- Derivative "disposed" entries at $0 reflect the conversion/exercise of options into shares (i.e., the derivative was converted), not a separate market sale.
Insider Transaction Report
Form 4
Pharvaris N.V.PHVS
Nijdam Anna
Principal Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-05-21$20.00/sh+1,829$36,580→ 50,774 total - Sale
Common Stock
[F2]2026-05-21$30.60/sh−1,829$55,971→ 48,945 total - Exercise/Conversion
Common Stock
2026-05-22$20.00/sh+5,501$110,020→ 54,446 total - Sale
Common Stock
[F3]2026-05-22$30.74/sh−5,501$169,084→ 48,945 total - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-05-21−1,829→ 28,171 totalExercise: $20.00Exp: 2031-02-05→ Common Stock (30,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-05-22−5,501→ 22,670 totalExercise: $20.00Exp: 2031-02-05→ Common Stock (30,000 underlying)
Footnotes (4)
- [F1]On April 14, 2026, the reporting person reported an RSU vesting transaction in which 5 additional shares were inadvertently reported as withheld for tax obligations, resulting in an understatement of total beneficial ownership. Following correction of the tax withholding share amount, total beneficial ownership as of April 11, 2026 should have been 48,945 shares rather than 48,940 shares reported previously.
- [F2]The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $30.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $31.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F4]25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.
Signature
/s/ Marnus Nel, Attorney-in-Fact for Anna Nijdam|2026-05-26